 |
|
|
| |
Efficacy and Safety of B/F/TAF in Treatment-Naïve People With HIV Aged ≥ 50 Years: 5-Year Follow-Up From Two Phase 3 Studies
|
| |
| |
IDWeek; October 16-19, 2024; Los Angeles, CA, USA
Cissy M Kityo1, Samir K Gupta2, Princy N Kumar3, Amy R Weinberg4, Bhumi Gandhi-Patel4, Hui Liu4,
Jason T Hindman4, Jurgen K Rockstroh5
1Joint Clinical Research Centre, Kampala, Uganda; 2Indiana University School of Medicine, Indianapolis, IN,
USA; 3Georgetown University Medical Center, Washington, DC, USA; 4Gilead Sciences, Inc.,
Foster City, CA, USA; 5University Hospital Bonn, Bonn, Germany
|
| |
|
|
|
|
|
